4.5 Article

HIV testing policies for migrants and ethnic minorities in EU/EFTA Member States

Journal

EUROPEAN JOURNAL OF PUBLIC HEALTH
Volume 24, Issue 1, Pages 139-144

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/eurpub/ckt108

Keywords

-

Funding

  1. European Centre for Disease Prevention and Control
  2. Spanish Network of HIV/AIDS Research [RIS- RD06/0006]
  3. Biomedical Research Centre Network for Epidemiology and Public Health [CIBER de Epidemiologia y Salud Publica]

Ask authors/readers for more resources

Background: In the context of an European Centre for Disease Prevention and Control (ECDC) research project, our objective was to describe current recommendations regarding HIV testing and counselling targeting migrants and ethnic minorities in the European Union/European Economic Area/European Free Trade Association (EU/EEA/EFTA) Member States. Methods: An on-line survey was conducted among 31 EU/EEA/EFTA Member States. The survey inquired on the existence of specific HIV testing and counselling recommendations or policies for migrants and/or ethnic minorities and the year of their publication. Additionally, we performed a review of national recommendations, guidelines or any other policy documents retrieved from an Internet search through the different countries' competent bodies. Results: Twenty-nine (94%) country representatives responded the survey, and 28 documents from 27 countries were identified. National guidelines on HIV testing are heterogeneous and tailored, according to the epidemiological situation. Twenty-two countries identify migrants and four countries identify ethnic minorities as particularly vulnerable to HIV. Sixteen countries explicitly recommend offering an HIV test to migrants/ethnic minorities. Guidelines especially target people originating from HIV endemic countries, and benefits of HIV early detection are highlighted. HIV testing is not mandatory in any country, but some countries overtly facilitate this practice. Conclusion: Benefits of HIV testing in migrants and ethnic minorities, at both individual and community levels are recognized by many countries. In spite of this, not all countries identify the need to test these groups.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Lifting COVID-19 mitigation measures in Spain (May-June 2020)

Susana Monge, Pello Latasa Zamalloa, Maria Jose Sierra Moros, Oscar Perez Olaso, Lucia Garcia San Miguel, Carmen Varela, Silvia Rivera Ariza, Maria C. Vazquez Torres, Maria del Carmen Olmedo Luceron, Paloma Gonzalez Yuste, Pilar Soler Crespo, Javier Segura del Pozo, Pedro Gullon, Jose Miguel Carrasco, Elena Vanessa Martinez Sanchez, Lidia Redondo Bravo, Myriam Pichiule Castaneda, Maria Jesus Purrinos Hermida, Xurxo Hervada Vidal, Ismael Huerta Gonzalez, Mario Margolles, Hermelinda Vanaclocha Luna, Enrique Ramalle Gomara, Jaime Jesus Perez Martin, Maria Dolores Chirlaque Lopez, Maria Jesus Lopez Fernandez, Nicola Lorusso, Alberto Carmona Ubago, Ana Rivas Perez, Violeta Ramos Marin, Juan Jose Criado Alvarez, Daniel Castrillejo Perez, Atanasio A. Gomez Anes, Marga Frontera, Pedro Macias Rodriguez, Eva Elisa alvarez Leon, Miriam Diaz Casanas, Maria Angeles Lopaz Perez, Juan Pablo Alonso Perez de Agreda, Paloma Navas Gutierrez, Ignacio Rosell Aguilar, Jose Maria Arteagoitia Axpe, Fernando Gonzalez Carril, Pilar Aparicio Azcarraga, Fernando Simon Soria, Berta Suarez Rodriguez

Summary: The study aims to describe the process of lifting the mitigation measures implemented in Spain due to the COVID-19 epidemic. By establishing a decision mechanism guided by quantitative and qualitative indicators, the government successfully achieved process control and reinforced core response capacities nationwide through systematic data collection and interterritorial dialogue.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2023)

Article Infectious Diseases

Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study

Susana Monge, Ayelen Rojas-Benedicto, Carmen Olmedo, Clara Mazagatos, Maria Jose Sierra, Aurora Limia, Elisa Martin-Merino, Amparo Larrauri, Miguel A. Hernan

Summary: The study estimated the effectiveness of mRNA-based vaccine boosters (third dose) against infection with the omicron variant of SARS-CoV-2 and analyzed it by age, sex, time since complete vaccination, type of primary vaccine, and type of booster. The results showed that the effectiveness of preventing infection with the omicron variant of SARS-CoV-2 was 51.3% within a month after receiving the booster, and the effectiveness increased with the time between completed primary vaccination and booster.

LANCET INFECTIOUS DISEASES (2022)

Article Immunology

Effectiveness of a Second Dose of an mRNA Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in Individuals Previously Infected by Other Variants

Susana Monge, Ayelen Rojas-Benedicto, Carmen Olmedo, Elisa Martin-Merino, Clara Mazagatos, Aurora Limia, Maria Jose Sierra, Amparo Larrauri, Miguel A. Hernan

Summary: During the Omicron period, a second dose of mRNA vaccine increased protection against SARS-CoV-2 reinfection by 62.2% (95% CI: 58.2-66.4%) among individuals with single-dose vaccination and previous infection, regardless of age, sex, first vaccine type, and time since the first dose. The estimated effectiveness was 65.4% (61.1-69.9%) for mRNA-1273 and 52.0% (41.8-63.1%) for BNT162b2. In the Delta period, there was no benefit observed from a second vaccine dose.

CLINICAL INFECTIOUS DISEASES (2023)

Article Multidisciplinary Sciences

Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales

Fatemeh Torabi, Stuart Bedston, Emily Lowthian, Ashley Akbari, Rhiannon K. Owen, Declan T. Bradley, Utkarsh Agrawal, Peter Collins, Richard Fry, Lucy J. Griffiths, Jillian Beggs, Gareth Davies, Joe Hollinghurst, Jane Lyons, Hoda Abbasizanjani, Simon Cottrell, Malorie Perry, Richard Roberts, Amaya Azcoaga-Lorenzo, Adeniyi Francis Fagbamigbe, Ting Shi, Ruby S. M. Tsang, Chris Robertson, F. D. Richard Hobbs, Simon de Lusignan, Colin McCowan, Michael Gravenor, Colin R. Simpson, Aziz Sheikh, Ronan A. Lyons

Summary: This study aimed to investigate the risk of thrombocytopenic, haemorrhagic, and thromboembolic events following COVID-19 vaccination and infection. The results showed an increased risk of haemorrhagic and idiopathic thrombocytopenic purpura events after the first dose of BNT162b2; a higher risk of arterial thrombosis after the second dose of ChAdOx1; a greater risk of venous thromboembolic events and arterial thrombosis after booster doses. In addition, there was an increased risk of haemorrhagic events, venous thromboembolic events, and arterial thrombosis post SARS-CoV-2 infection.

SCIENTIFIC REPORTS (2022)

Article Education & Educational Research

Effectiveness of a game-based educational strategy e-EDUCAGUIA for implementing antimicrobial clinical practice guidelines in family medicine residents in Spain: a randomized clinical trial by cluster

Isabel del Cura-Gonzalez, Gloria Ariza-Cardiel, Elena Polentinos-Castro, Juan A. Lopez-Rodriguez, Teresa Sanz-Cuesta, Jaime Barrio-Cortes, Blanca Andreu-Ivorra, Ricardo Rodriguez-Barrientos, Jose F. Avila-Tomas, Elisa Gallego-Ruiz-de-Elvira, Cristina Lozano-Hernandez, Jesus Martin-Fernandez

Summary: This study evaluated the impact of a game-based educational strategy, e-EDUCAGUIA, on the decision-making skills of family medicine residents. The results showed that e-EDUCAGUIA had a positive effect on knowledge and skills in the short term, but dropout rates were high.

BMC MEDICAL EDUCATION (2022)

Review Medicine, General & Internal

Prevalence of polypharmacy in pregnancy: a systematic review

Astha Anand, Katherine Phillips, Anuradhaa Subramanian, Siang Ing Lee, Zhaonan Wang, Rebecca McCowan, Utkarsh Agrawal, Adeniyi Frances Fagbamigbe, Catherine Nelson-Piercy, Peter Brocklehurst, Christine Damase-Michel, Maria Loane, Krishnarajah Nirantharakumar, Amaya Azcoaga-Lorenzo

Summary: The objective of this review is to investigate the prevalence of polypharmacy among pregnant women and its association with maternal and offspring outcomes. The study found a high proportion of women being prescribed two or more medications during pregnancy, but there is a lack of reporting on multimorbidity and the impact of polypharmacy on pregnancy and offspring outcomes.

BMJ OPEN (2023)

Article Medicine, General & Internal

Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UK

Siang Ing Lee, Holly Hope, Dermot O'Reilly, Lisa Kent, Gillian Santorelli, Anuradhaa Subramanian, Ngawai Moss, Amaya Azcoaga-Lorenzo, Adeniyi Francis Fagbamigbe, Catherine Nelson-Piercy, Christopher Yau, Colin McCowan, Jonathan Ian Kennedy, Katherine Phillips, Megha Singh, Mohamed Mhereeg, Neil Cockburn, Peter Brocklehurst, Rachel Plachcinski, Richard D. Riley, Shakila Thangaratinam, Sinead Brophy, Sudasing Pathirannehelage Buddhika Hemali Sudasinghe, Utkarsh Agrawal, Zoe Vowles, Kathryn Mary Abel, Krishnarajah Nirantharakumar, Mairead Black, Kelly-Ann Eastwood, MuM PreDiCT

Summary: This observational study aims to compare maternal and child outcomes for pregnant women with multiple long-term conditions to those without multiple long-term conditions. Data from routine health records in the UK and the Born in Bradford birth cohort will be used to examine the association of multiple long-term conditions with various outcomes. The results will be published in peer-reviewed journals and presented at conferences.

BMJ OPEN (2023)

Article Medical Informatics

Prevalence and demographic variation of cardiovascular, renal, metabolic, and mental health conditions in 12 million english primary care records

Jennifer Cooper, Krishnarajah Nirantharakumar, Francesca Crowe, Amaya Azcoaga-Lorenzo, Colin Mccowan, Thomas Jackson, Aditya Acharya, Krishna Gokhale, Niluka Gunathilaka, Tom Marshall, Shamil Haroon

Summary: This study analyzed a large primary care database in England to investigate the prevalence and socio-demographic variation of cardiovascular, renal, and metabolic (CRM) conditions and mental health (MH) conditions. The study found variations in prevalence by sex and ethnicity, suggesting potential differences in clinical presentation and practice. It also highlighted the underrepresentation of undiagnosed conditions, particularly in mental health, in primary care data.

BMC MEDICAL INFORMATICS AND DECISION MAKING (2023)

Article Medicine, General & Internal

The development of a core outcome set for studies of pregnant women with multimorbidity

Siang Ing Lee, Stephanie Hanley, Zoe Vowles, Rachel Plachcinski, Ngawai Moss, Megha Singh, Chris Gale, Adeniyi Francis Fagbamigbe, Amaya Azcoaga-Lorenzo, Anuradhaa Subramanian, Beck Taylor, Catherine Nelson-Piercy, Christine Damase-Michel, Christopher Yau, Colin McCowan, Dermot O'Reilly, Gillian Santorelli, Helen Dolk, Holly Hope, Katherine M. Phillips, Kathryn Abel, Kelly-Ann Eastwood, Lisa Kent, Louise Locock, Maria Loane, Mohamed Mhereeg, Peter Brocklehurst, Sharon McCann, Sinead Brophy, Steven Wambua, Sudasing Pathirannehelage Buddhika Hemali Sudasinghe, Shakila Thangaratinam, Krishnarajah Nirantharakumar, Mairead Black, MuM PreDiCT Grp

Summary: This study developed a core outcome set for pregnant women with multimorbidity, aiming to address the heterogeneity in reported outcomes and improve the synthesis of research evidence. The core outcome set was developed through a systematic literature search, focus groups, Delphi surveys, and consensus meetings. It includes 11 outcomes, covering maternal and child outcomes.

BMC MEDICINE (2023)

Article Medicine, General & Internal

Maternal multimorbidity and preterm birth in Scotland: an observational record-linkage study

Amaya Azcoaga-Lorenzo, Adeniyi Francis Fagbamigbe, Utkarsh Agrawal, Mairead Black, Muhammad Usman, Siang Ing Lee, Kelly-Ann Eastwood, Ngawai Moss, Rachel Plachcinski, Catherine Nelson-Piercy, Sinead Brophy, Dermot O'Reilly, Krishnarajah Nirantharakumar, Colin Mccowan

Summary: This study aims to estimate the prevalence of multimorbidity in pregnant women and examine the association between maternal multimorbidity and preterm birth. The results showed that multimorbidity was present in one in six women and was associated with an increased risk of preterm birth. Routine and comprehensive evaluation of women with multimorbidity before and during pregnancy is urgently needed to address the significant health burden it imposes.

BMC MEDICINE (2023)

Article Obstetrics & Gynecology

Key outcomes for reporting in studies of pregnant women with multiple long-term conditions: a qualitative study

Siang Ing Lee, Stephanie Hanley, Zoe Vowles, Rachel Plachcinski, Amaya Azcoaga-Lorenzo, Beck Taylor, Catherine Nelson-Piercy, Colin McCowan, Dermot O'Reilly, Holly Hope, Kathryn M. M. Abel, Kelly-Ann Eastwood, Louise Locock, Megha Singh, Ngawai Moss, Sinead Brophy, Krishnarajah Nirantharakumar, Shakila Thangaratinam, Mairead Black

Summary: This study conducted a qualitative research to inform a core outcome set for studies of pregnant women with multiple long-term conditions. The findings identified 63 outcomes in total, including maternal, children's, and health care utilization outcomes. The study also revealed that women and partners had higher expectations for involvement in care decisions and being informed about the risks, while health care professionals emphasized non-clinical and longer-term outcomes.

BMC PREGNANCY AND CHILDBIRTH (2023)

Article Health Care Sciences & Services

Trajectories in chronic disease accrual and mortality across the lifespan in Wales, UK (2005-2019), by area deprivation profile: linked electronic health records cohort study on 965,905 individuals

Jane Lyons, Ashley Akbari, Keith R. Abrams, Amaya Azcoaga Lorenzo, Thamer Ba Dhafari, James Chess, Spiros Denaxas, Richard Fry, Chris P. Gale, John Gallacher, Lucy J. Grif, Bruce Guthrie, Marlous Hall, Farideh Jalali-najafabadi, Ann John, Clare Macrae, Colin Mccowan, Niels Peek, Dermot Oreilly, James Rafferty, Ronan A. Lyons, Rhiannon K. Owen

Summary: This study aimed to measure chronic disease accrual and examine the differences in disease development and mortality between different socioeconomic groups in Wales, UK. The results showed that individuals living in more deprived areas were diagnosed with chronic diseases earlier and had a higher risk of premature death compared to their counterparts in less deprived areas.

LANCET REGIONAL HEALTH-EUROPE (2023)

Meeting Abstract Obstetrics & Gynecology

Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: A population-based cross-sectional study

Siang Ing Lee, Amaya Azcoaga-Lorenzo, Utkarsh Agrawal, Jonathan Ian Kennedy, Adeniyi Francis Fagbamigbe, Mairead Black

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Meeting Abstract Obstetrics & Gynecology

Polypharmacy during pregnancy: A retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019

Anuradhaa Subramanian, Amaya Azcoaga-Lorenzo, Astha Anand, Katherine Phillips, Siang Ing Lee, Neil Cockburn

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Review Health Care Sciences & Services

Lessons learnt from COVID-19 surveillance. Urgent need for a new public health surveillance. SESPAS Report 2022

Maria Jose Sierra Moros, Elena Vanessa Martinez Sanchez, Susana Monge Corella, Lucia Garcia San Miguel, Berta Suarez Rodriguez, Fernando Simon Soria

Summary: This article provides important epidemiological aspects and preliminary reflections from the Coordinating Centre for Health Alerts and Emergencies during the early phases of the COVID-19 pandemic. The weaknesses in the surveillance system and the challenges of managing a health crisis without a robust public health structure have been highlighted. The commitment of public health professionals has compensated for resource limitations and emphasized the need for incorporating new profiles into surveillance teams. Rapid adaptation has led to improvements in existing systems and the development of new tools. Structural changes are necessary to enhance surveillance quality, reduce territorial disparities, and ensure a coordinated response to future health crises. Incorporating tools for process automation and ensuring timely availability of data are urgent priorities. Public health and epidemiological surveillance need to be actively involved in the digital development of the National Health System. Integration of public health surveillance at all healthcare levels and strengthening analytical capacity through partnerships and joint actions are important. The importance of coordination in a decentralized country has been evident during this alert. At the international level, reviewing data sharing tools for early-stage coordination is necessary.

GACETA SANITARIA (2022)

No Data Available